• Title of article

    Retrograde nontransseptal balloon mitral valvuloplasty: immediate results and intermediate long-term outcome in 441 cases— multicenter experience

  • Author/Authors

    Christodoulos I. Stefanadis، نويسنده , , Costas G. Stratos، نويسنده , , Spyros G. Lambrou، نويسنده , , Vinay Kumar Bahl، نويسنده , , Dennis V. Cokkinos، نويسنده , , Vassilios A. Voudris، نويسنده , , Stefanos G. Foussas، نويسنده , , Costas P. Tsioufis، نويسنده , , Pavlos K. Toutouzas، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 1998
  • Pages
    8
  • From page
    1009
  • To page
    1016
  • Abstract
    Objectives. Our aim was to present the immediate and intermediate long-term results of the application of retrograde nontransseptal balloon mitral valvuloplasty (RNBMV) in four cooperating centers from Greece and India. Background. RNBMV is purely transarterial method of balloon valvuloplasty, developed with the aim to avoid complications associated with transseptal catheterization. Only single-center experience with RNBMV has been previously reported. Methods. The procedure was attempted in 441 patients with symptomatic mitral stenosis (320 women, 121 men, mean age [± SD] 44 ± 11 years, mean echocardiographic score [± SD] 7.7 ± 2.0) from 1988 to 1996. Three hundred eighty-five patients with successful immediate outcome were followed clinically for mean [± SD] of 3.5 ± 1.9 (range, 0.5–9.1) years. Results. technically successful procedure was achieved in 388 (88%) cases. The echocardiographic score (p < 0.001), male gender (p = 0.005), preprocedural mitral regurgitation (p = 0.007) and previous surgical commissurotomy (p = 0.029) were unfavorable predictors of immediate outcome. Complications included death (0.2%), severe mitral regurgitation (3.4%) and injury of the femoral artery (1.1%). Event-free (freedom from cardiac death, mitral valve surgery, repeat valvuloplasty and NYH class > II symptoms) survival rates (± SEM) were 100%, 96.9 ± 0.9%, 89.8 ± 1.9% and 75.5 ± 5.5% at 1, 2, 4 and 9 years, respectively. The echocardiographic score (p < 0.001), NYH class (p = 0.008) and postprocedural mitral valve are (p = 0.009) were significant independent predictors of intermediate long-term outcome. Conclusions. Multicenter experience indicates that RNBMV is safe and effective technique for the treatment of symptomatic mitral stenosis. As with the transseptal approach, patients with favorable mitral valve anatomy derive the greatest immediate and intermediate long-term benefit from this procedure.
  • Keywords
    Left ventricle , follow-up , MR , Left ventricular , LA , FA , femoral artery , LV , NYHA , New York Heart Association , mitral regurgitation , MVA , mitral valve area , left atrium , left atrial , MVR , mitral valve replacement , RNBMV , retrograde nontransseptal balloon mitral valvuloplasty , FU
  • Journal title
    JACC (Journal of the American College of Cardiology)
  • Serial Year
    1998
  • Journal title
    JACC (Journal of the American College of Cardiology)
  • Record number

    480854